Burning Rock Biotech Limited 1Q2023 results Nasdaq and LSE: BNR 30 May 2023 Disclaimer This presentation has been prepared by Burning Rock Biotech Limited (the "Company") solely for information purpose and has not been independently verified. No representations, warranties or undertakings, express or implied, are made by the Company or any of its affiliates, advisers, or representatives as to, and no reliance should be placed upon, the accuracy, fairness, completeness or correctness of the information or op ...

Burning Rock Biotech Limited (NASDAQ:BNR) Q1 2023 Earnings Conference Call May 30, 2023 8:00 AM ET Company Participants Yusheng Han - Founder, Chairman & CEO Leo Li - CFO Joe Zhang - CTO Conference Call Participants Alexis Yan - Morgan Stanley Operator Good day, and thank you, for standing by. Welcome to the Burning Rock’s 2023 Q1 Earnings Conference Call. Before we begin, I’d like to remind you that this conference call contains forward-looking statements within the meaning of Section 21(e) of the Securiti ...

Exhibit 99.1 Burning Rock Reports First Quarter 2023 Financial Results GUANGZHOU, China, May 30, 2023—Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the "Company" or "Burning Rock"), a company focused on the application of next generation sequencing (NGS) technology in the field of precision oncology, today reported financial results for the three months ended March 31, 2023. Recent Business Updates • Minimal Residual Disease (MRD) • Results of the MEDAL (MEthylation Based Dynamic Analysis for Lung ...

Table of Contents Title of each classTrading SymbolName of each exchange on which registered American depositary shares, each representing one Class A ordinary share BNR The Nasdaq Stock Market LLC (The Nasdaq Global Market) Class A ordinary share, par value US$0.0002 per share* The Nasdaq Stock Market LLC (The Nasdaq Global Market) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES ACT OF 1 ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2023 Commission File Number: 001-39316 BURNING ROCK BIOTECH LIMITED (Registrant's Name) No.5 Xingdao Ring Road North, International Bio Island Guangzhou, Guangdong People's Republic of China (Address of principal executive offices) Indicate by check mark whether the registrant files or will file an ...

Burning Rock Biotech Limited 4Q2022 results Nasdaq and LSE: BNR 28 Mar 2023 Disclaimer This presentation has been prepared by Burning Rock Biotech Limited (the "Company") solely for information purpose and has not been independently verified. No representations, warranties or undertakings, express or implied, are made by the Company or any of its affiliates, advisers, or representatives as to, and no reliance should be placed upon, the accuracy, fairness, completeness or correctness of the information or op ...

Burning Rock Biotech Limited (NASDAQ:BNR) Q4 2022 Earnings Conference Call March 28, 2023 8:00 AM ET Company Participants Yusheng Han - Founder, Chairman and Chief Executive Officer Joe Zhang - CTO Leo Li - CFO Conference Call Participants Alexis Yan - Morgan Stanley Operator Before we begin, I’d like to remind you that this conference call contains forward-looking statements within the meaning of Section 21(e) of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities ...

Exhibit 99.1 Burning Rock Reports Fourth Quarter and Full Year 2022 Financial Results GUANGZHOU, China, March 28, 2023—Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the "Company" or "Burning Rock"), a company focused on the application of next generation sequencing (NGS) technology in the field of precision oncology, today reported financial results for the three months and the year ended December 31, 2022. 2022 Business Overview and Recent Updates • Corporate • Listed on the Main Market of the Lo ...

Burning Rock Biotech Limited (NASDAQ:BNR) Q3 2022 Earnings Conference Call November 16, 2022 8:30 AM ET Company Participants Yusheng Han - Chairman and CEO Dr. Shaokun Chuai - COO Leo Li - CFO Conference Call Participants Alexis Yan - Morgan Stanley Max Masucci - Cowen & Company Operator Good day and thank you for standing by. Welcome to the Burning Rock 2022 Third Quarter Earnings Conference Call. At this time, all participants are in listen-only mode. After the speakers’ presentation, there will be a ques ...